The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
about
Anticoagulant treatment for subsegmental pulmonary embolismHeparin versus placebo for non-ST elevation acute coronary syndromesAnticoagulant treatment for subsegmental pulmonary embolismAnticoagulant treatment for subsegmental pulmonary embolismHeparin versus placebo for acute coronary syndromesEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesManagement of Venous Thromboembolisms: Part I. The Consensus for Deep Vein ThrombosisDeep Venous Thrombosis: An Interventionalist's ApproachPharmacology of anticoagulants used in the treatment of venous thromboembolismGuidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismSafety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleedingClinical use of new antithrombotic therapies for medical management of acute coronary syndromesEfficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients.A data-driven approach to optimized medication dosing: a focus on heparinEarly intervention in massive pulmonary embolism. A guide to diagnosis and triage for the critical first hour.Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin.Limitations of traditional anticoagulants.Heparin overview and issues.Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.Update on heparin: what do we need to know?[Treatment of venous thromboembolism].Heparin in interventional radiology: a therapy in evolutionEvaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesEvaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia.Contemporary use of and future roles for heparin in antithrombotic therapy.Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspective.Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes.Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations.Low molecular weight heparins and coronary artery disease.Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade.Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.Anticoagulation therapy in patients with venous thromboembolic diseaseThe story of the discovery of heparin and warfarin.Dosing of unfractionated heparin in obese patients with venous thromboembolism.Venous thrombosis in children.Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.Do anticoagulants improve survival in patients presenting with venous thromboembolism?
P2860
Q24186514-0E5AD73E-90DD-4A31-BD1A-D8131E0ACEB4Q24193744-9B3FE993-C2D4-4942-B9F2-7D75DC7EE117Q24194990-8AD9C6FC-709C-46B5-AA67-6EAE30176512Q24197722-20F034B1-B7D3-4EF6-BA26-F1713049201BQ24243000-5DC54FC4-7A69-4EA7-B5E9-EB27EC58B789Q24632951-13771528-1442-49E8-9528-AF1B2CF5C6AFQ24633053-65B57F64-F755-4AE7-9356-A1AE2983BBFAQ26749273-7B1189C0-F027-4C25-BE85-370E4F2D042BQ26827598-E6F766E6-6091-49AC-BC4D-112C3FB794C1Q28078967-81B2CAF4-708B-4084-8406-7FC60E9268C2Q28079081-D699AE0B-8B75-4E34-B433-5A202D8B24CBQ28166487-F87EFD9C-189F-4CA0-BB2D-461020D59B06Q28177271-1DCDE098-E6BA-49E7-A7CD-CCC2245C58EFQ30352952-5FA00AE0-9D18-4769-9130-648C7DFDAF64Q30840644-441458D1-F23E-4499-A91D-DD1BB127E8A2Q33147513-19FA8640-9336-41E9-B5DB-C3E6D1649AE7Q33331821-C701C705-F759-46DE-B138-12820D5728FAQ33362181-D49CEB1F-43F3-4232-BE51-C54F9B638CC1Q33362316-2D49F436-62A2-4159-ABA3-27CD4E8744BBQ33377146-DF0D4ADA-80C3-40C0-B73A-695DFDFCB610Q33382677-CDB9A889-CE5E-4966-8DFE-B2509FDD1774Q33386920-631534F0-A6DC-469C-A06D-A9721C6CCDF5Q33387992-584CCDEC-23B3-4E57-9FF9-3321CF55853DQ33394179-D63BA7F5-558C-4A88-AED4-9973D51DD259Q33394199-E5011F30-57C2-4002-B4EE-6F0A64EB8F6AQ33399576-F625F81F-0226-420F-814E-1717C94CEDECQ33409923-9D921C54-32C3-440E-A380-98206CB8A73BQ33495687-A7859398-51C2-4D71-A69F-57B289FF860BQ33803415-6E544C1D-2979-46A2-961A-2E806E4FE1A2Q33838920-22AE18FD-1513-40BA-A238-7B51DBF1D534Q33931460-93E67D6C-2F19-4751-A76D-A61A53D0F76AQ34027403-8137529F-0F8E-493D-BECE-0ED7F040783AQ34239129-D7585719-28FB-4CEC-9DA9-CF4714E04152Q34492516-F8F093E1-D958-4F49-BE98-C9F0D0827797Q34751947-46938802-4A64-4A50-81AA-7BF0F28D03A6Q34763634-AA735302-C1F6-4006-BD95-DD08DFC112AFQ34798985-02171DF7-42E7-4003-BB9F-1A30AD5BBD21Q35181611-0A7D0822-5F39-4ADD-BBF5-65831C24E339Q35525678-DE90B5AA-C71F-4B53-8652-42BA25244198Q35594629-C0655152-7240-43DB-A564-8F3E13D7817F
P2860
The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
The weight-based heparin dosin ...... A randomized controlled trial.
@en
The weight-based heparin dosin ...... A randomized controlled trial.
@nl
type
label
The weight-based heparin dosin ...... A randomized controlled trial.
@en
The weight-based heparin dosin ...... A randomized controlled trial.
@nl
prefLabel
The weight-based heparin dosin ...... A randomized controlled trial.
@en
The weight-based heparin dosin ...... A randomized controlled trial.
@nl
P2093
P1476
The weight-based heparin dosin ...... A randomized controlled trial.
@en
P2093
P304
P356
10.7326/0003-4819-119-9-199311010-00002
P407
P577
1993-11-01T00:00:00Z